T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent

被引:31
作者
Davidson, WF
Haudenschild, C
Kwon, J
Williams, MS
机构
[1] Amer Red Cross, Holland Lab, Dept Immunol, Rockville, MD 20855 USA
[2] Amer Red Cross, Holland Lab, Dept Expt Pathol, Rockville, MD 20855 USA
[3] George Washington Univ, Dept Immunol, Inst Biol Sci, Washington, DC 20037 USA
关键词
D O I
10.4049/jimmunol.169.11.6218
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Short-term culture of activated T cells with IL-2 renders them highly susceptible to apoptotic death triggered by TCR cross-linking. Activation-induced apoptosis is contingent upon caspase activation and this is mediated primarily by Fas/Fas ligand (FasL) interactions that, in turn, are optimized by p38 mitogen-activated protein kinase(MAPK)-regulated signals. Although T cells from mice bearing mutations in Fas (lpr) or FasL (gld) are more resistant to activation-induced cell death (AICD) than normal T cells, a significant proportion of CD8(+) T cells and to a lesser extent CD4(+) T cells from mutant mice die after TCR religation. Little is known about this Fas-independent death process. In this study, we demonstrate that AICD in lpr and gld CD4(+) and CD8(+) T cells occurs predominantly by a novel mechanism that is TNF-alpha-, caspase-, and p38 MAPK-independent and has morphologic features more consistent with oncosis/primary necrosis than apoptosis. A related Fas- and caspase-independent, nonapoptotic death process is revealed in wild-type (WT) CD8(+) T cell blasts following TCR ligation and treatment with caspase inhibitors, the p38 MAPK inhibitor, SB203580, or neutralizing anti-FasL mAb. In parallel studies with WT CD4(+) T cells, two minor pathways leading to nonapoptotic, caspase-independent AICD were identified, one contingent upon Fas ligation and p38 MAPK activation and the other Fas- and p38 MAPK-independent. These data indicate that TCR ligation can activate nonapoptotic death programs in WT CD8(+) and CD8(+) T blasts that normally are masked by Fas-mediated caspase activation. Selective use of potentially proinflammatory oncotic death programs by activated lpr and gld T cells may be an etiologic factor in autosensitization.
引用
收藏
页码:6218 / 6230
页数:13
相关论文
共 71 条
  • [1] Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs
    Albert, ML
    Sauter, B
    Bhardwaj, N
    [J]. NATURE, 1998, 392 (6671) : 86 - 89
  • [2] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
    Albert, ML
    Pearce, SFA
    Francisco, LM
    Sauter, B
    Roy, P
    Silverstein, RL
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1359 - 1368
  • [3] Supraoptimal peptide major histocompatibility complex causes a decrease in Bcl-2 levels and allows tumor necrosis factor α receptor II-mediated apoptosis of cytotoxic T lymphocytes
    Alexander-Miller, MA
    Derby, MA
    Sarin, A
    Henkart, PA
    Berzofsky, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) : 1391 - 1399
  • [4] ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
  • [5] Activation-induced cell death
    Budd, RC
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (03) : 356 - 362
  • [6] Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure
    Cocco, RE
    Ucker, DS
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) : 919 - 930
  • [7] COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
  • [8] LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE
    COHEN, PL
    EISENBERG, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 : 243 - 269
  • [9] Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis
    Daugas, E
    Susin, SA
    Zamzami, N
    Ferri, KF
    Irinopoulou, T
    Larochette, N
    Prévost, MC
    Leber, B
    Andrews, D
    Penninger, J
    Kroemer, G
    [J]. FASEB JOURNAL, 2000, 14 (05) : 729 - 739
  • [10] DAVIDSON WF, 1986, J IMMUNOL, V136, P4075